REFERENCES
- Itri LM. Optimal hemoglobin level in cancer patients. Semin Oncol. 2000;27:12–15.
- Ludwig H, Pecorelli S. Suboptimal hemoglobin levels: impact on patients and therapy. Semin Oncol. 2000;27:18–19.
- Coiffier B. Impact and management of anemia in hematological malignancies. Med Oncol. 2000;17:S2–S10.
- Demetri GD. Anemia and its functional consequences in cancer patients current challenges in management and prospects for improving therapy. Br J Cancer. 2001;84:31–37.
- Pasricha SR, Black J, Muthayya S, Determinants of anemia among young children in rural India. Pediatrics. 2010;126:e140–e149.
- Michon J. Incidence of anemia in pediatric cancer patients in Europe: results of a large, international survey. Med Pediatr Oncol. 2002;39:448–450.
- Patel AR, Shah PC, Vohra RM, Serum ferritin levels in hematologic malignancies. Arch Pathol Lab Med. 1980;104:509–512.
- Aulbert E, Schmidt CG. Ferritin—a tumor marker in myeloid leukemia. Cancer Detect Prev. 1985;8:297–302.
- Morita R, Yoshii M, Nakajima K, Clinical evaluation of serum ferritin to iron ratio in malignant diseases. Eur J Nucl Med. 1981;6(7):331–336.
- Madanat F, EI-khateeb M, Tarawaneh M, Hijazi S. Serum ferritin in evaluation of iron status in children. Acta Haematol. 1984;71:111–115.
- Waters JS, O'Brein ME, Ashley S. Management of anemia in patients receiving chemotherapy. J Clin Oncol. 2001;19:2865–2874.
- Ruggiero A, Riccardi R. Interventions for anemia in pediatric cancer patients [review]. Med Pediatr Oncol. 2002;39:451–454.